Skip to Main Content

Paper Details

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.
0
2023
Anti-AGE, Arthritis, C reactive protein, HLA, HLA class II, HLA-DRB1*03, MAA, RA, RA arthritis, acetaldehyde, anti-AGE, anti-AGE IgG antibody, anti-MAA, anti-MAA antibodies, anti-PTM, arthritis, erythrocyte, genetic, joint, malondialdehyde, malondialdehyde-, non, non-RA arthritis, patients, rheumatoid arthritis, rheumatoid factor, seronegative, seronegative arthritis
Author NameAffiliation
Tom W J HuizingaLeiden University Medical Center
Annette H M van der Helm-van MilLeiden University Medical Center
Annette H M van der Helm-van MilErasmus Medical Center
René E M ToesLeiden University Medical Center
  • 1 - 4

Datasets

Release 1.2